All In Biotech

Drug Trial Radar · NCT06697301

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK1001 and Pembrolizumab Versus Placebo and Pembrolizumab as First-Line Therapy in Participants With Advanced Melanoma (TeLuRide-006)

Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 740 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

740

Planned (sponsor's estimate)

Start

May 22, 2025

Primary completion

Dec 2035

Study completion Dec 2040

Sponsor

Lead sponsor
Eikon TherapeuticsIndustry
Sponsor type
Industry
Collaborators
Merck Sharp & Dohme LLC
First posted
Nov 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab.

Conditions

  • Advanced Melanoma

Interventions

  • EIK1001Drug

    EIK1001 is a Toll-like receptor 7/8 (TLR 7/8) dual agonist.

  • Pembrolizumab (KEYTRUDA® )Drug

    Pembrolizumab is a PD-1 inhibitor.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free Survival (PFS)Time frame: up to 5 years
  2. Overall survival (OS)Time frame: up to 5 years
  3. Objective Response (OR) (Dose Optimization Only)Time frame: up to 5 years
  4. Adverse Events (AEs) (Dose Optimization Only)Time frame: up to 2.5 years

Locations

127 sites in 24 countries. Site status is shown where the registry gives one.

  • Ironwood Cancer & Research Centers

    Chandler, Arizona · Recruiting

  • Genesis Cancer and Blood Institute

    Hot Springs, Arkansas · Recruiting

  • Helios Clinical Research

    Los Angeles, California · Recruiting

  • Providence Medical Foundation

    Santa Rosa, California · Recruiting

  • UCHealth Memorial Hospital Central

    Colorado Springs, Colorado · Recruiting

  • Christiana Care

    Newark, Delaware · Recruiting

  • Bioresearch Partner

    Hialeah, Florida · Recruiting

  • Florida Clinical Trials Group - Tamarac

    Tamarac, Florida · Recruiting

  • The Center for Cancer and Blood Disorders

    Bethesda, Maryland · Recruiting

  • MidAmerica Cancer Care

    Kansas City, Missouri · Recruiting

  • Washington University School of Medicine in St. Louis

    St Louis, Missouri · Recruiting

  • Gabrail Cancer Center Research LLC

    Canton, Ohio · Recruiting

  • University of Pittsburgh Medical Center(UPMC)-Hillman Cancer Center

    Pittsburgh, Pennsylvania · Recruiting

  • Patientcare Clinical Research

    Sugar Land, Texas · Recruiting

  • Cancer Care Wollongong

    Wollongong, New South Wales, Australia · Recruiting

  • Icon Cancer Centre Chermside

    Chermside, Queensland, Australia · Recruiting

  • Southern Adelaide Local Health Network Incorporated Flinders Medical Centre

    Bedford Park, South Australia, Australia · Recruiting

  • Eastern Health

    Box Hill, Victoria, Australia · Recruiting

  • Peninsula and South Eastern Haematology and Oncology Group

    Frankston, Victoria, Australia · Recruiting

  • Universitätsklinikum Graz

    Graz, Styria, Austria · Recruiting

  • Vitaz Primary Location

    Sint-Niklaas, Belgium · Recruiting

  • Universitair Ziekenhuis Antwerpen

    Edegem, Antwerpen, Belgium · Recruiting

  • Cliniques Universitaires Saint-Luc

    Brussels, Brussels Capital, Belgium · Recruiting

  • Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne

    Yvoir, Namur, Belgium · Recruiting

  • Universitair Ziekenhuis Leuven - Campus Gasthuisberg

    Leuven, Vlaams Brabant, Belgium · Recruiting

  • Algemeen Ziekenhuis Groeninge - Campus Kennedylaan

    Kortrijk, West-Vlaanderen, Belgium · Recruiting

  • Sunnybrook Research Ins<tute

    Toronto, Ontario, Canada · Recruiting

  • Masaryk Memorial Cancer Institute

    Brno, Brno, Czechia · Recruiting

  • University Hospital Hradec Kralove

    Sokolov, Hradce Kralove, Czechia · Recruiting

  • Aarhus Universitetshospital

    Aarhus, Central Jutland, Denmark · Suspended

  • Aalborg University Hospital

    Aalborg, Nord Jutland, Denmark · Suspended

  • Oulu University Hospital

    Oulu, Oulu, Finland · Recruiting

  • Tampere University Hospital

    Tampere, Pirkanmaa, Finland · Recruiting

  • Helsinki University Hospital

    Helsinki, Uusimaa, Finland · Recruiting

  • Hospital Saint Andre

    Bordeaux, France · Recruiting

  • Centre Hospitalier Lyon-Sud

    Pierre-Bénite, Auvergne-Rhône-Alpes, France · Recruiting

  • A Paré

    Boulogne, Boulogne, France · Recruiting

  • Centre Hospitalier Universitaire Grenoble Alpes

    La Tronche, Isère, France · Recruiting

  • CHU Lille

    Lille, Lille Cedex, France · Recruiting

  • Hôpital La Timone

    Marseille, Marseille, France · Recruiting

Showing 40 of 127 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.